💊Merck's FTZ 49 Notification for Pharmaceutical Production Activity
Merck, Sharp & Dohme LLC has submitted a notification to the Foreign-Trade Zones Board for proposed production activities at its facility in Rahway, New Jersey. The notification includes plans for various pharmaceutical products intended for research and development, alongside a list of foreign-status materials and components that will benefit from FTZ procedures. Public commentary is invited ahead of the final approval.
Learn More💊Merck Authorized for Production in Foreign-Trade Zone 49
The Foreign-Trade Zones Board has authorized Merck, Sharp & Dohme LLC to conduct production activities for pharmaceutical products within FTZ 49 in Rahway, New Jersey. This decision follows a review process, indicating compliance with federal regulations and allowing for enhanced operational support in the pharmaceutical sector.
Learn More